Sight Sciences, Inc. (SGHT)
NASDAQ$2.88
Market Cap
$147.84M
Sector
Healthcare
Industry
Medical—Devices
Rank in Sector
101 of 924
Rank in Industry
6 of 118
Insider Buys Sum
Cluster
Trading
Trading
Insider Buys
Quantity
Quantity
Historical
Profitability
Profitability
Investor
Ownership
Ownership
Largest Insider Buys in Sector
SGHT Insider Trading Activity
SGHT Median Price and Trade Amounts History Chart
Statistics of Insider Transactions
Amount of Insider Buys and Sells
Buys | $2,169,695 | 7 | 19 |
Sells | $3,451,486 | 30 | 81 |
Related Transactions
| Encrantz Staffan | 1 | $2.06M | 1 | $2.06M | $0 | |
| Raheja Manohar K. | EVP, Research & Development | 6 | $111,473 | 0 | $0 | $111,473 |
| Park Sam Boong | Chief Operating Officer | 0 | $0 | 3 | $59,927 | $-59,927 |
| Badawi David | Chief Technology Officer | 0 | $0 | 6 | $93,434 | $-93,434 |
| HAYDEN JEREMY B. | Chief Legal Officer | 0 | $0 | 6 | $128,191 | $-128,191 |
| Bauerlein Alison | Chief Financial Officer | 0 | $0 | 5 | $284,662 | $-284,662 |
| Badawi Paul | President and CEO | 0 | $0 | 5 | $337,271 | $-337,271 |
| Link Matthew | Chief Commercial Officer | 0 | $0 | 4 | $489,779 | $-489,779 |
About Sight Sciences, Inc.
Sight Sciences, Inc., an ophthalmic medical device company, engages in the development and commercialization of surgical and nonsurgical technologies for the treatment of eye diseases. The company's products include OMNI Surgical System, a therapeutic device used by ophthalmic surgeons to reduce intraocular pressure in adult glaucoma patients; and TearCare System, a wearable eyelid technology for the treatment of dry eye disease (DED) for ophthalmologists and optometrists. It offers its products through sales representatives and distributors to …
Insider Activity of Sight Sciences, Inc.
Over the last 12 months, insiders at Sight Sciences, Inc. have bought $2.17M and sold $3.45M worth of Sight Sciences, Inc. stock.
On average, over the past 5 years, insiders at Sight Sciences, Inc. have bought $12.07M and sold $10.16M worth of stock each year.
Highest buying activity among insiders over the last 12 months: Encrantz Staffan () — $2.06M. Raheja Manohar K. (EVP, Research & Development) — $111,473.
The last purchase of 10,000 shares for transaction amount of $26,000 was made by Raheja Manohar K. (EVP, Research & Development) on 2025‑03‑13.
List of Insider Buy and Sell Transactions, Sight Sciences, Inc.
| 2025-03-13 | Raheja Manohar K. | EVP, Research & Development | 10,000 0.0211% | $2.60 | $26,000 | +15.83% | ||
| 2025-03-12 | Raheja Manohar K. | EVP, Research & Development | 10,000 0.0197% | $2.73 | $27,250 | +2.23% | ||
| 2025-01-17 | Sale | Badawi David | Chief Technology Officer | 5,423 0.0106% | $2.78 | $15,081 | -3.62% | |
| 2025-01-17 | Sale | HAYDEN JEREMY B. | Chief Legal Officer | 6,922 0.0135% | $2.78 | $19,250 | -3.62% | |
| 2025-01-16 | Sale | Badawi Paul | President and CEO | 24,819 0.0499% | $2.92 | $72,571 | -3.87% | |
| 2025-01-08 | Sale | Badawi David | Chief Technology Officer | 3,829 0.0074% | $3.26 | $12,479 | -17.02% | |
| 2025-01-08 | Sale | HAYDEN JEREMY B. | Chief Legal Officer | 1,810 0.0035% | $3.26 | $5,899 | -17.02% | |
| 2025-01-03 | Sale | Badawi David | Chief Technology Officer | 3,111 0.0062% | $3.52 | $10,957 | -20.34% | |
| 2025-01-03 | Sale | Bauerlein Alison | Chief Financial Officer | 10,102 0.02% | $3.52 | $35,579 | -20.34% | |
| 2025-01-03 | Sale | HAYDEN JEREMY B. | Chief Legal Officer | 4,864 0.0096% | $3.52 | $17,131 | -20.34% | |
| 2025-01-02 | Sale | Badawi Paul | President and CEO | 12,236 0.0243% | $3.60 | $44,013 | -22.21% | |
| 2024-12-06 | Raheja Manohar K. | EVP, Research & Development | 5,000 0.0099% | $3.85 | $19,250 | -25.58% | ||
| 2024-12-03 | Raheja Manohar K. | EVP, Research & Development | 3,376 0.0067% | $3.89 | $13,133 | -25.26% | ||
| 2024-11-29 | Raheja Manohar K. | EVP, Research & Development | 4,624 0.0091% | $3.99 | $18,441 | -27.19% | ||
| 2024-11-21 | Sale | Encrantz Staffan | 551,802 1.07% | $3.73 | $2.06M | -21.28% | ||
| 2024-11-21 | Encrantz Staffan | 551,802 1.07% | $3.73 | $2.06M | -21.28% | |||
| 2024-11-19 | Raheja Manohar K. | EVP, Research & Development | 2,000 0.0039% | $3.70 | $7,400 | -21.22% | ||
| 2024-10-21 | Sale | Link Matthew | Chief Commercial Officer | 21,831 0.0441% | $5.61 | $122,450 | -38.32% | |
| 2024-10-18 | Sale | Link Matthew | Chief Commercial Officer | 20,487 0.0408% | $5.98 | $122,451 | -42.88% | |
| 2024-10-17 | Sale | Link Matthew | Chief Commercial Officer | 20,970 0.0409% | $5.84 | $122,444 | -42.02% |
Total: 61
*Gray background shows transactions not older than one year
Insider Historical Profitability
48.42%
| Encrantz Staffan | 4573920 8.9103% | $13.17M | 17 | 1 | +62.13% | |
| Raheja Manohar K. | EVP, Research & Development | 155000 0.302% | $446,400.00 | 6 | 0 | |
| D1 Capital Partners L.P. | 10 percent owner | 3000000 5.8442% | $8.64M | 1 | 1 | <0.0001% |
| Selnick Jesse | Chief Financial Officer | 249225 0.4855% | $717,768.00 | 2 | 0 | <0.0001% |
*Gray background shows insiders who have made transactions during last year
SGHT Institutional Investors: Active Positions
| Increased Positions | 50 | +66.67% | 4M | +19.39% |
| Decreased Positions | 29 | -38.67% | 3M | -14.95% |
| New Positions | 18 | New | 1M | New |
| Sold Out Positions | 14 | Sold Out | 2M | Sold Out |
| Total Postitions | 96 | +28% | 23M | +4.44% |
SGHT Ownership Change vs Market
Institutional Investor Ownership
Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
| Kck Ltd. | $11,900.00 | 8.58% | 4.37M | -271,891 | -5.85% | 2024-12-31 |
| Ubs Group Ag | $6,379.00 | 4.6% | 2.35M | -187,221 | -7.39% | 2024-12-31 |
| Blackrock, Inc. | $6,358.00 | 4.58% | 2.34M | +101,576 | +4.54% | 2024-12-31 |
| Long Focus Capital Management, Llc | $6,089.00 | 4.39% | 2.24M | +1M | +158.77% | 2024-12-31 |
| Vanguard Group Inc | $4,444.00 | 3.2% | 1.63M | -56,818 | -3.36% | 2024-12-31 |
| Bank Of America Corp /De/ | $3,656.00 | 2.64% | 1.34M | -760,647 | -36.14% | 2024-12-31 |
| Prosight Management, Lp | $2,472.00 | 1.78% | 908,847 | +377,625 | +71.09% | 2024-12-31 |
| Geode Capital Management, Llc | $2,157.00 | 1.56% | 792,860 | +8,731 | +1.11% | 2024-12-31 |
| Apollo Management Holdings, L.P. | $1,827.00 | 1.32% | 671,520 | 0 | 0% | 2024-12-31 |
| State Street Corp | $1,796.00 | 1.29% | 660,178 | +13,402 | +2.07% | 2024-12-31 |
Financial Ratios
Summary
Comparison with Competitors
Analyst Recommendations
Analyst Price Targets
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny StocksPrismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.